The Europe Cell Viability Assays Market would witness market growth of 9.0% CAGR during the forecast period (2022-2028).
A commonly measured parameter in the cell viability assays is the integrity of the membrane. Cell-impermeant is membrane integrity dyes that can only enter live cells when there is a compromised plasma membrane. Usually, the membrane integrity viability dyes are made of Nucleic acid binding dyes and amine-reactive dyes.
A nucleic acid binding dye is nonfluorescent in aqueous media but shows increased fluorescence after joining with a double standard DNA or RNA. Propidium iodide (PI), SYTOX dead cell stains, and 7 amino actinomycin D (7 AAD) are some nucleic acid viability dyes. Amine reactive dyes bind covalently with the primary amine group available on the cellular proteins, which are present on the interior and exterior of the cells.
The signal is weak when the amine proteins are attached to the surface but showcases high signal intensity when the dye penetrates the cell with a compromised plasma membrane and reacts with the interior amine cellular protein. For flow cytometry, amine-reactive viability dyes contain live/dead fixable dead cell stains.
The German Federal Ministry of Education and Research (BMBF) published a medical information funding scheme on 16 November 2015 and a corresponding call for proposals, underlining the recognition of digitalization’s increasing role in healthcare and the potential to enhance treatment and diagnostics through the adoption of IT in medical research.
The Germany market dominated the Europe Cell Viability Assays Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $160.4 million by 2028. The UK market is anticipated to grow at a CAGR of 8.1% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 9.9% during (2022 - 2028).
Based on Product, the market is segmented into Consumables (Reagents & Assay Kits and Microplates) and Instruments (Spectrophotometer, Microscopy, Cell Imaging & Analysis System, Flow Cytometry, and Others). Based on Reagents & Assay Kits, the market is segmented into Luminometric Assays, Dye Exclusion Assays, Colorimetric Assays, and Fluorometric Assays. Based on End User, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Academic & Research Institutes, and Diagnostic Labs. Based on Application, the market is segmented into Stem Cell Research, Drug Discovery & Development, and Diagnostics. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Cell Viability Assays Market will Hit $2.5 Billion by 2028, at a CAGR of 9.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Merck KGaA, Becton, Dickinson and Company, PerkinElmer Inc., Promega Corporation, Biotium, Creative Bioarray, and Abcam Plc.
By Product
By End User
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 